Cargando…
Precision Medicine in Oncology and Immuno-Oncology: Where We Stand and Where We're Headed
BACKGROUND/AIMS: Precision medicine has only been a clinical reality only since the start of the 21st century, spurred on by the coevolution of science and technologies, as well as the increasing medical needs of aging societies of industrialized countries. Its overarching objective, from the perspe...
Autor principal: | Scheuenpflug, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945891/ https://www.ncbi.nlm.nih.gov/pubmed/31988938 http://dx.doi.org/10.1159/000481878 |
Ejemplares similares
-
Pediatric urologic oncology in the 21(st) century: where we stand and where we’re headed
por: Routh, Jonathan C., et al.
Publicado: (2020) -
TSACO’s Third Anniversary: where we were, where we are, and where we’re going
por: Fabian, Timothy
Publicado: (2019) -
Precision oncology for upper GI cancers – Where are we heading?
por: Quante, Michael
Publicado: (2021) -
Hypothyroidism in Context: Where We’ve Been and Where We’re Going
por: Chiovato, Luca, et al.
Publicado: (2019) -
Pediatric chylothorax: where we’ve been and where we’re going
por: Winder, Melissa, et al.
Publicado: (2023)